Skip to main content

AgoraSign in

Zellnor Myrie

Sponsor · State Senator, District 20 · Democratic

Follow

Senate bill · S438 (2025-26)

Establishes the prescription drug supply chain transparency act

Latest action Mar 24, 2026

Summary

Establishes the prescription drug supply chain transparency act; requires pharmacy services administrative organizations, pharmacy switch companies and rebate aggregators to register with the insurance department and to provide certain disclosures relating to the ownership and activities of such entities; relates to deposits into the pharmacy benefit manager regulatory fund.

Your position on this bill

Not chosen yet

Sign in to choose

Where it stands

Passed one of the two chambers; it still needs the other.

  1. Introduced
  2. In committee
  3. Up for a vote
  4. Passed one chamber
  5. Passed
  6. Enacted

New York State Senate

Amends the Insurance Law.

Committee

Insurance · New York State Assembly

Also referred to Insurance · New York State Senate.

Purpose, from the sponsor's memo

Requires registration and disclosures by Pharmacy Services Administra- tive Organizations (PSA0s), switch companies, and rebate aggregators to the Department of Financial Services (DFS). SUMMARY: Section 1 names the act the "Prescription Drug Supply Chain Transparency Act." Section 2 adds Article 30 to the Insurance Law (sections 3001-3010), defining manufacturer, PSAO, rebate aggregator, and switch company; requires electronic filings, special reports, investigations by the DFS Superintendent, registration, and disclosures; and directs fees and penalties to the Pharmacy Benefit Manager Regulatory Fund under State Finance Law section 99-oo. Section 3 amends State Finance Law section 99-oo to deposit collected fees and penalties into the fund. Section 4 sets the effective date.

Filed with the bill. Read it on nysenate.gov (opens in a new tab)

Recorded votes

  • Vote: Floor vote

    NY SenateMar 24, 2026Result: passed

    (57) (4) (0) (2)
  • Vote: Floor vote

    NY SenateFeb 24, 2026Result: passed

    (54) (2) (0) (7)
  • Vote: Committee vote · Insurance

    Senate InsuranceFeb 9, 2026Result: passed

    (11) (0) (0) (0)
  • Vote: Floor vote

    NY SenateFeb 25, 2025Result: passed

    (57) (4) (0) (2)
  • Vote: Committee vote · Insurance

    Senate InsuranceFeb 3, 2025Result: passed

    (11) (0) (0) (0)

The sponsor's argument

Why Zellnor Myrie says this is needed

Rising drug costs burden New Yorkers. Intermediaries such as PBMs, PSAOs, switch companies, and rebate aggregators operate with little oversight and may engage in conflicts of interest, anticompetitive, or deceptive practices that raise costs. Federal scrutiny has increased, including a 2022 FTC inquiry and a 2023 U.S. House investigation. The bill increases transparency and accountability through annual registra- tion, conflict disclosures, and audited financial reporting.

This is the sponsor's own case for the bill, quoted from their memorandum. It is not Agora's description of what the bill does.

Full history

  1. Mar 24, 2026

    Referred to committee

    REFERRED TO INSURANCE

    NY Assembly

  2. Mar 24, 2026

    Passed a chamber

    REPASSED SENATE

    NY Senate

  3. Mar 24, 2026

    Returned to Assembly

    RETURNED TO ASSEMBLY

    NY Senate

  4. Feb 25, 2026

    Amended

    AMENDED ON THIRD READING 438A

    NY Senate

  5. Feb 25, 2026

    Recalled From Assembly

    RECALLED FROM ASSEMBLY

    NY Senate

Show full history (16 earlier events)
  1. Feb 25, 2026

    Returned to Senate

    RETURNED TO SENATE

    NY Assembly

  2. Feb 24, 2026

    Sent to the executive

    DELIVERED TO ASSEMBLY

    NY Senate

  3. Feb 24, 2026

    Passed a chamber

    PASSED SENATE

    NY Senate

  4. Feb 24, 2026

    Referred to committee

    REFERRED TO INSURANCE

    NY Assembly

  5. Feb 11, 2026

    Advanced to Third Reading

    ADVANCED TO THIRD READING

    NY Senate

  6. Feb 10, 2026

    2ND Report CAL.

    2ND REPORT CAL.

    NY Senate

  7. Feb 9, 2026

    1ST Report CAL.296

    1ST REPORT CAL.296

    NY Senate

  8. Jan 7, 2026

    Died in Assembly

    DIED IN ASSEMBLY

    NY Assembly

  9. Jan 7, 2026

    Referred to committee

    REFERRED TO INSURANCE

    NY Senate

  10. Feb 25, 2025

    Sent to the executive

    DELIVERED TO ASSEMBLY

    NY Senate

  11. Feb 25, 2025

    Passed a chamber

    PASSED SENATE

    NY Senate

  12. Feb 25, 2025

    Referred to committee

    REFERRED TO INSURANCE

    NY Assembly

  13. Feb 5, 2025

    Advanced to Third Reading

    ADVANCED TO THIRD READING

    NY Senate

  14. Feb 4, 2025

    2ND Report CAL.

    2ND REPORT CAL.

    NY Senate

  15. Feb 3, 2025

    1ST Report CAL.232

    1ST REPORT CAL.232

    NY Senate

  16. Jan 8, 2025

    Referred to committee

    REFERRED TO INSURANCE

    NY Senate

About this record

Summary

The summary comes from NY Open Legislation, the New York State Senate's public record. For more, see How we handle summaries.

Cosponsors

The list shows the cosponsors who are on Agora, A to Z. The official record may list more.

Party colors

Parties are shown in the same neutral colors.

Source

From NY Open Legislation, the NY Senate and Assembly, and official rosters. This record was last updated Oct 29, 2026. About our data

Read the record

Follow